Back
Praxis Precision Medicines Vs. Protagonist Therapeutics Industry Stock Comparison
Sell
45
PRAX
Praxis Precision Medicines
Last Price:
72.23
Seasonality Move:
88.65%
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
46.48
Seasonality Move:
13.32%
Sell
45
Praxis Precision Medicines (PRAX)
is a Sell
Is Praxis Precision Medicines a Buy, Sell or Hold?
- The current Praxis Precision Medicines [PRAX] share price is $72.25. The Score for PRAX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PRAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $46.44. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRAX Stock Price Chart
What is Praxis Precision Medicines's stock price today?
-
The Praxis Precision Medicines share price today is $72.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $46.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.03 | Buy |
| Relative Strength Index (14 RSI): | 64.61 | Buy |
| Chaikin Money Flow: | -61353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.98 - 69.28) | Buy |
| Bollinger Bands (100): | (44.35 - 62.25) | Buy |
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 57.18 | Buy |
| Chaikin Money Flow: | 263579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.25 - 46.57) | Buy |
| Bollinger Bands (100): | (34.19 - 44.65) | Buy |
PRAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.2 | Buy |
| 20-day SMA: | 64.62 | Buy |
| 50-day SMA: | 59.11 | Buy |
| 200-day SMA: | 50.51 | Buy |
| 8-day EMA: | 70.5 | Buy |
| 20-day EMA: | 66.23 | Buy |
| 50-day EMA: | 60.8 | Buy |
| 200-day EMA: | 49.76 | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.13 | Buy |
| 20-day SMA: | 45.3 | Buy |
| 50-day SMA: | 43.96 | Buy |
| 200-day SMA: | 33.5 | Buy |
| 8-day EMA: | 46.13 | Buy |
| 20-day EMA: | 45.45 | Buy |
| 50-day EMA: | 43.49 | Buy |
| 200-day EMA: | 34.83 | Buy |
Praxis Precision Medicines Earnings Growth & PRAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.92 per share, and a decrease next year of $0.31 per share.
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Praxis Precision Medicines Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protagonist Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||